A Medsky Topics feed composed of posts covering recent news related to the U.S. Food and Drug Administration Powered by @medsky.network

17
Likes
+0
Growth per month

In the feed right now

Live from Bluesky
Ian Weissman, DO @drianweissman.bsky.social · about 1 hour ago
Some adults with chronic hepatitis B may now have a path to something today’s treatments rarely deliver — stopping all medication while the virus stays in check. www.healthday.com/health-….
FDA Approves Hepatitis B Shot That May Let Some Patients Stop All Treatment

www.healthday.com

FDA Approves Hepatitis B Shot That May Let Some Patients Stop All Treatment

FRIDAY, Oct. 23, 2026 (HealthDay News) — Some adults with chronic hepatitis B may now have a path to something today’s treatments rarely deliver — stopping all

Replies0 Reposts1 Likes4
American Association for Cancer Research (AACR) @theaacr.bsky.social · about 1 hour ago
This week in cancer news: People with blood cancers often face financial barriers to oral medications, the FDA approves an immunotherapy for certain rectal cancers, and more. buff.ly/3JEjQt8
Replies0 Reposts0 Likes0
The Cancer Letter @cancerletter.com · about 4 hours ago
Dostarlimab becomes first FDA-approved immunotherapy for locally advanced rectal cancer Patients now have an alternative to the brutal, life-altering standard of care cancerletter.com/regulato…
Close-up of a syringe needle inserted into a small glass vaccine vial with a blurred blue and pink background.
Replies0 Reposts0 Likes0
WGN NEWS @wgntv.com · about 4 hours ago
The FDA has designated the recall as Class II, meaning exposure to the products could cause reversible or temporary health consequences and poses little risk of serious consequences from use, according to the FDA website. More: tinyurl.com/yc2et4uz 
Image 1
Replies0 Reposts0 Likes1
Keep reading on Bluesky